Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-25-024290
Filing Date
2025-08-01
Accepted
2025-08-01 08:30:51
Documents
20

Document Format Files

Seq Description Document Type Size
1 FORM S-3 dmtp20250728_s3.htm S-3 421450
2 EXHIBIT 5.1 ex_845142.htm EX-5.1 10395
3 EXHIBIT 23.1 ex_846261.htm EX-23.1 3613
4 EXHIBIT FILING FEES ex_845143.htm   iXBRL EX-FILING FEES 17336
5 a01.jpg GRAPHIC 83677
6 a02.jpg GRAPHIC 4238
7 dm.jpg GRAPHIC 5098
8 pmfooter.jpg GRAPHIC 14934
9 pmlogo.jpg GRAPHIC 20736
10 pmlogosmall.jpg GRAPHIC 3117
  Complete submission text file 0001437749-25-024290.txt   751888

Data Files

Seq Description Document Type Size
22 EXTRACTED XBRL INSTANCE DOCUMENT ex_845143_htm.xml XML 4168
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-289159 | Film No.: 251174035
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)